Clinical Trials Directory

Trials / Completed

CompletedNCT00472160

Preoxygenation Using NIV in Hypoxemic Patients

Preoxygenation Using Noninvasive Ventilation Prior Intubation in Hypoxemic Patients

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Critically ill patients are predisposed to oxyhaemoglobin desaturation during intubation. For the intubation of hypoxemic patients, preoxygenation using non invasive ventilation (NIV) is more effective at reducing arterial oxyhaemoglobin desaturation than standard method. Objectives: To find out whether NIV, as a preoxygenation method, is more effective at reducing the degree of organ dysfunction/failure than standard preoxygenation during the week following endotracheal intubation.

Detailed description

During the inclusion period (at least 10 min and maximum 30 min), the patients ware a high FiO2 mask, driven by 10-15L/min oxygen and are randomly assigned to control or NIV group. Preoxygenation is then performed for a 3 minute period prior to a standardized rapid sequence intubation. For the control group, preoxygenation use a non-re-breather bag-valve mask driven by 15L/min oxygen. Patients allow to breath spontaneously with occasional assists (usual preoxygenation method). For the NIV group, pressure support mode is delivered by an ICU ventilator through a face mask adjusted to obtain an expired tidal volume of 7 to 10 mL/kg. The fraction of inspired oxygen (FiO2) was 100% and we used a PEEP level of 5 cmH2O.

Conditions

Interventions

TypeNameDescription
PROCEDURENon Invasive VentilationNon Invasive Ventilation

Timeline

Start date
2007-06-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2007-05-11
Last updated
2011-03-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00472160. Inclusion in this directory is not an endorsement.